New Twice-Yearly HIV shot could revolutionize prevention for south african youth
NCT ID NCT07390409
First seen Feb 05, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study will offer young people aged 15-35 in Cape Town a choice of HIV prevention methods, including a new twice-yearly injection called lenacapavir, a two-monthly injection (cabotegravir), or daily pills. The goal is to see which option people stick with best and how to deliver these choices effectively in clinics and mobile health trucks. The study will follow 3,700 participants for 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
DTHF Mobile Clinics
Cape Town, WC, 7925, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.